Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

LTB4-PPARalpha as a new target for drug design

Nov. 20, 1996

U.S. patents and suits related to transgenic mice producing human antibodies

Nov. 15, 1996

Patent covers Advanced Magnetics' targeted drug delivery system

Nov. 15, 1996

Alanex and Aurora join forces to identify new lead compounds

Nov. 15, 1996

CombiChem/Roche Bioscience drug discovery collaboration

Nov. 15, 1996

NIU researchers offer improved vector delivery system for ribozymes

Nov. 8, 1996

Scherer-Merck softgel development agreement

Nov. 8, 1996

CellPro to begin clinical trial of T-cell depletion system

Nov. 1, 1996

Lynx signs two agreements with BASF

Nov. 1, 1996

Strategy and outlook for HemaSure's blood pathogen inactivation system

Nov. 1, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...